Evidence map›Paper›PMID 34012805›Full record

ReviewTranslational lung cancer research2021

Preoperative and postoperative radiotherapy (RT) for non-small cell lung cancer: still an open question.

Paul Van Houtte, Luigi Moretti, Florian Charlier, Martine Roelandts, Dirk Van Gestel

Abstract readReview
In one paragraph

Review in Translational lung cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Paul Van HoutteDepartment of Radiation Oncology, Institut Jules Bordet, Université Libre Bruxelles, Brussels, Belgium.
Luigi MorettiDepartment of Radiation Oncology, Institut Jules Bordet, Université Libre Bruxelles, Brussels, Belgium.
Florian CharlierDepartment of Radiation Oncology, Institut Jules Bordet, Université Libre Bruxelles, Brussels, Belgium.
Martine RoelandtsDepartment of Radiation Oncology, Institut Jules Bordet, Université Libre Bruxelles, Brussels, Belgium.
Dirk Van GestelDepartment of Radiation Oncology, Institut Jules Bordet, Université Libre Bruxelles, Brussels, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Preoperative and postoperative radiotherapy (PORT) with or without chemotherapy has been used in non-small cell lung cancer (NSCLC) for decades. Numerous trials have investigated the potential survival benefit of this strategy, but despite greater knowledge of the disease, considerable technological developments in imaging and radiotherapy, and significant progress in surgery, many questions remain unsolved. In this review, we summarize the current knowledge on this problem and discuss issues which still require elucidation.

Indexed as

Lung cancerpostoperative radiotherapy (PORT)preoperative radiotherapy (preRT)

Identifiers

PMID34012805
PMCPMC8107767

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.